Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Pre-trained encoders for offline feature extraction followed by multiple
instance learning (MIL) aggregators have become the dominant paradigm in
computational pathology (CPath), benefiting cancer diagnosis and prognosis.
However, performance limitations arise from the absence of encoder fine-tuning
for downstream tasks and disjoint optimization with MIL. While slide-level
supervised end-to-end (E2E) learning is an intuitive solution to this issue, it
faces challenges such as high computational demands and suboptimal results.
These limitations motivate us to revisit E2E learning. We argue that prior work
neglects inherent E2E optimization challenges, leading to performance
disparities compared to traditional two-stage methods. In this paper, we
pioneer the elucidation of optimization challenge caused by sparse-attention
MIL and propose a novel MIL called ABMILX. It mitigates this problem through
global correlation-based attention refinement and multi-head mechanisms. With
the efficient multi-scale random patch sampling strategy, an E2E trained ResNet
with ABMILX surpasses SOTA foundation models under the two-stage paradigm
across multiple challenging benchmarks, while remaining computationally
efficient (<10 RTX3090 hours). We show the potential of E2E learning in CPath
and calls for greater research focus in this area. The code is
https://github.com/DearCaat/E2E-WSI-ABMILX.
Authors (7)
Wenhao Tang
Rong Qin
Heng Fang
Fengtao Zhou
Hao Chen
Xiang Li
+1 more
Key Contributions
This paper revisits end-to-end (E2E) learning for computational pathology, arguing that prior work overlooked optimization challenges. It proposes ABMILX, a novel MIL method that mitigates issues in sparse-attention MIL through global correlation-based attention refinement and multi-head mechanisms, enabling more effective E2E learning with slide-level supervision.
Business Value
Accelerates cancer diagnosis and prognosis by improving the accuracy and efficiency of computational pathology tools, potentially leading to earlier detection and better patient outcomes.